Menu
Menu
Research & Development
Innovation is an integral part of our DNA.
Research & Development
Innovation is an integral part of our DNA.
Innovation is an integral part of our DNA.
Innovation is an integral part of our DNA.
Our R&D unit
One of the priorities of our R&D team is to provide precise, reliable and relevant dosimetric information. Our goal: meet the expectations of medical and paramedical teams in their clinical routine, as well as those of scientific partners.
To achieve this, our team of experts is always ready to listen to our customers’ needs, and includes them in our discussions on product and service improvements.
Our know-how
Dosimetry
Medical Physics
Scintillating optical fiber
Connected devices
Software
Smart data
Our clinical partners
To test and improve our systems, we collaborate closely with clinical centers, hospitals and private companies.
Our academic partners
For many years now we have been working together with the research unit INSERM U 1296 “Radiations: defense, health, environment”. Fibermetrix and U1296 pool their respective expertise on physical and biological dose to allow a better assessment of radiation risk induced in patients and workers exposed to ionizing radiation in concrete exposure situations.
A study in progress with Neolys Diagnostics aims to map the biological effects and associated dose of image-guided radiotherapy treatments (CBCT). This work will enable us to better understand the effects of low doses of radiation encountered in medical radiodiagnostics, and to establish clinical recommendations according to the type of patient concerned (radiosensitivity / radio-susceptibility).
Our industrial partners
+33 (0)3 69 71 97 10
7 Allée de l'Europe
67960 Entzheim
France
